Cornelia Kropf-Sanchen

693 total citations
18 papers, 254 citations indexed

About

Cornelia Kropf-Sanchen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Cornelia Kropf-Sanchen has authored 18 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Cornelia Kropf-Sanchen's work include Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Obstructive Sleep Apnea Research (3 papers). Cornelia Kropf-Sanchen is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Obstructive Sleep Apnea Research (3 papers). Cornelia Kropf-Sanchen collaborates with scholars based in Germany, United States and United Kingdom. Cornelia Kropf-Sanchen's co-authors include Thomas Wibmer, K Stoiber, Stefan G. Rüdiger, Christian Schumann, Stefan Rüdiger, Christian Schumann, Wolfgang Rottbauer, Michael Thomas, Manuel Eichenlaub and Rainer Brucher and has published in prestigious journals such as Annals of Oncology, Journal of Thoracic Oncology and Lung Cancer.

In The Last Decade

Cornelia Kropf-Sanchen

16 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornelia Kropf-Sanchen Germany 8 87 78 65 64 61 18 254
M. Rafiei United States 11 82 0.9× 90 1.2× 74 1.1× 41 0.6× 9 0.1× 37 287
T Honda Japan 9 16 0.2× 161 2.1× 63 1.0× 92 1.4× 6 0.1× 32 311
Kari Struemph United States 8 30 0.3× 24 0.3× 60 0.9× 28 0.4× 73 1.2× 16 243
Laith Mukdad United States 8 62 0.7× 42 0.5× 11 0.2× 34 0.5× 28 0.5× 18 252
A Bourgoin France 8 16 0.2× 34 0.4× 34 0.5× 31 0.5× 30 0.5× 18 230
David J. Patton Canada 10 37 0.4× 184 2.4× 105 1.6× 86 1.3× 3 0.0× 27 292
Carlos Tornero Spain 9 10 0.1× 56 0.7× 28 0.4× 28 0.4× 21 0.3× 38 274
Francisco Buendía Fuentes Spain 13 81 0.9× 252 3.2× 94 1.4× 52 0.8× 12 0.2× 52 506
Raffaella Pizzolato Umeton United States 10 9 0.1× 33 0.4× 66 1.0× 59 0.9× 13 0.2× 15 349
Pedro Engel Gonzalez United States 10 26 0.3× 148 1.9× 78 1.2× 72 1.1× 4 0.1× 44 303

Countries citing papers authored by Cornelia Kropf-Sanchen

Since Specialization
Citations

This map shows the geographic impact of Cornelia Kropf-Sanchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Kropf-Sanchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Kropf-Sanchen more than expected).

Fields of papers citing papers by Cornelia Kropf-Sanchen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia Kropf-Sanchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Kropf-Sanchen. The network helps show where Cornelia Kropf-Sanchen may publish in the future.

Co-authorship network of co-authors of Cornelia Kropf-Sanchen

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia Kropf-Sanchen. A scholar is included among the top collaborators of Cornelia Kropf-Sanchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia Kropf-Sanchen. Cornelia Kropf-Sanchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Saalfeld, Felix Carl, Michael Rost, Charles Elias Assmann, et al.. (2024). 1300P Treatment sequences in BRAF-V600-mutant non-small cell lung cancer: First-line targeted therapy versus first-line (chemo-) immunotherapy. Annals of Oncology. 35. S827–S828.
2.
Jonigk, Danny, et al.. (2024). Neoadjuvante Therapie des resektablen, nicht-kleinzelligen Lungenkarzinoms. Pneumologie. 79(1). 16–24.
3.
Bozorgmehr, Farastuk, et al.. (2023). Immune checkpoint inhibitors in non-small cell lung cancer – When should we dare to stop treatment?. Lung Cancer. 184. 107340–107340. 2 indexed citations
4.
Imhof, Armin, Cornelia Kropf-Sanchen, Manuel Rattka, et al.. (2021). Long COVID: Distinction between Organ Damage and Deconditioning. Journal of Clinical Medicine. 10(17). 3782–3782. 26 indexed citations
5.
Kropf-Sanchen, Cornelia, et al.. (2019). Image-based biomarkers for low-risk NSCLC using texture analysis of F-18-FDG-PET/CT: determination of optimal parameters and their prognostic threshold. 60. 88–88. 3 indexed citations
6.
Eichenlaub, Manuel, et al.. (2017). Validation of a New System Using Tracheal Body Sound and Movement Data for Automated Apnea-Hypopnea Index Estimation. Journal of Clinical Sleep Medicine. 13(10). 1123–1130. 7 indexed citations
7.
Eichenlaub, Manuel, et al.. (2017). Apnea and heart rate detection from tracheal body sounds for the diagnosis of sleep-related breathing disorders. Medical & Biological Engineering & Computing. 56(4). 671–681. 21 indexed citations
8.
Christopoulos, Petros, Walburga Engel-Riedel, Christian Grohé, et al.. (2017). Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial. Annals of Oncology. 28(8). 1898–1902. 53 indexed citations
9.
Grohé, Christian, Walburga Engel-Riedel, Cornelia Kropf-Sanchen, et al.. (2017). P1.07-003 A Phase II Study Evaluating the Combination of Everolimus with Carboplatin/Paclitaxel as 1st Line Treatment in Patients with Advanced LCNEC. Journal of Thoracic Oncology. 12(1). S697–S697. 1 indexed citations
10.
11.
Wibmer, Thomas, et al.. (2015). Blood pressure monitoring during exercise: Comparison of pulse transit time and volume clamp methods. Blood Pressure. 24(6). 353–360. 23 indexed citations
12.
Wibmer, Thomas, Cornelia Kropf-Sanchen, Stefan G. Rüdiger, et al.. (2014). Pulse Transit Time and Blood Pressure During Cardiopulmonary Exercise Tests. Physiological Research. 63(3). 287–296. 60 indexed citations
13.
Wibmer, Thomas, et al.. (2014). Relation of Exercise Capacity With Lung Volumes Before and After 6-Minute Walk Test in Subjects With COPD. Respiratory Care. 59(11). 1687–1695. 7 indexed citations
14.
Wibmer, Thomas, et al.. (2013). Isolated IgG4-related interstitial lung disease: unusual histological and radiological features of a pathologically proven case. Multidisciplinary Respiratory Medicine. 8(1). 22–22. 18 indexed citations
15.
Wibmer, Thomas, Thierry Berghmans, Cornelia Kropf-Sanchen, et al.. (2013). Histology as a Potential Clinical Predictor of Outcome in Advanced Non-Small-Cell Lung Cancer Treated with Vinorelbine and Mitomycin Combination Chemotherapy. Lung. 191(3). 271–280. 2 indexed citations
16.
Wibmer, Thomas, et al.. (2013). Effects of Nasal Positive Expiratory Pressure on Dynamic Hyperinflation and 6-Minute Walk Test in Patients With COPD. Respiratory Care. 59(5). 699–708. 18 indexed citations
17.
Wibmer, Thomas, et al.. (2013). Isolated IgG4-related interstitial lung disease: unusual histological and radiological features of a pathologically proven case. Multidisciplinary Respiratory Medicine. 8. 2 indexed citations
18.
Wibmer, Thomas, Christoph Fischer, Stefanie Brunner, et al.. (2013). Impact of continuous, non-invasive blood pressure measurement on sleep quality during polysomnography. Sleep and Biological Rhythms. 11(4). 254–260. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Rafiei Breakdown of academic impact, for papers by T Honda Breakdown of academic impact, for papers by Kari Struemph Breakdown of academic impact, for papers by Laith Mukdad Breakdown of academic impact, for papers by A Bourgoin Breakdown of academic impact, for papers by David J. Patton Breakdown of academic impact, for papers by Carlos Tornero Breakdown of academic impact, for papers by Francisco Buendía Fuentes Breakdown of academic impact, for papers by Raffaella Pizzolato Umeton Breakdown of academic impact, for papers by Pedro Engel Gonzalez
Rankless by CCL
2026